XTX Topco »

Inhibrx shares owned by XTX Topco

Quarter-by-quarter ownership of Inhibrx (INBX) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Inhibrx

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx by XTX Topco

Quarter filed Position value Share count Share price at filing
2023-09-30 $300k 16k 18.35

More positions owned by XTX Topco

Eli Lilly & Co. (LLY)
Anthem (ELV)
IDEXX Laboratories (IDXX)
Activision Blizzard
W.W. Grainger (GWW)
Visa Com Cl A (V)
TransDigm Group Incorporated (TDG)
Vertex Pharmaceuticals Incorporated (VRTX)
Microsoft Corporation (MSFT)
Cummins (CMI)
Nike CL B (NKE)
American Express Company (AXP)
Hf Sinclair Corp (DINO)
Deckers Outdoor Corporation (DECK)
Automatic Data Processing (ADP)

View all positions for XTX Topco

Top funds holding Inhibrx

Viking Global Investors
RA Capital Management
Perceptive Advisors
Vanguard Group
Arrowpoint Asset Management
Bank of America Corporation
Logos Global Management
Partner Fund Management
Russell Investments
Citadel Advisors
Caption Management
Millennium Management
Charles Schwab Investment Management
Sphera Funds Management
Two Sigma Advisers

View all funds holding Inhibrx